Until more information is available, patients with cardiovascular disease should not take CJC-1295.
Mounjaro: Fast-Acting Weight Loss with a Dual Approach Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors , delivering a dual-action effect that controls appetite and boosts insulin sensitivity
Clinical studies show that while it can last for several weeks initially, the digestive system often adapts over time
Support for sustainable habits: Medication may help reduce appetite, but lifestyle habits help maintain progress
Anti-inflammatory activity Garlic-derived organosulfur compounds have been found to inhibit mediators of the inflammatory response, including cytokines, chemokines, adhesion molecules, and enzymes like cyclooxygenase (COX), lipoxygenase (LOX), and inducible nitric oxide synthase (iNOS) (34-36)